SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults
NCT ID: NCT00259792
Last Updated: 2011-01-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1000 participants
INTERVENTIONAL
2004-09-30
2006-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
NCT00652392
Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
NCT00385593
SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults
NCT00238784
STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma
NCT00252824
Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting
NCT00235911
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Budesonide/formoterol Turbuhaler
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AstraZeneca France Medical Director, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Abbeville, , France
Research Site
Agen, , France
Research Site
Ajaccio, , France
Research Site
Albi, , France
Research Site
Alès, , France
Research Site
Ambérieu-en-Bugey, , France
Research Site
Amiens, , France
Research Site
Angers, , France
Research Site
Angoulême, , France
Research Site
Apt, , France
Research Site
Arles, , France
Research Site
Aubagne, , France
Research site
Avignon, , France
Research Site
Avrillé, , France
Research Site
Bastia, , France
Research Site
Bayonne, , France
Research Site
Béthune, , France
Research Site
Béziers, , France
Research Site
Biarritz, , France
Research Site
Blois, , France
Research Site
Bois-Guillaume, , France
Research Site
Bordeaux, , France
Research Site
Boulogne-Billancourt, , France
Research Site
Bourgoin, , France
Research Site
Brest, , France
Research Site
Briey, , France
Research Site
Bron, , France
Research Site
Cabestany, , France
Research Site
Cachan, , France
Research Site
Caen, , France
Research Site
Cagnes-sur-Mer, , France
Research Site
Cambrai, , France
Research Site
Carcassonne, , France
Research Site
Castelnau-le-Lez, , France
Research site
Challans, , France
Research Site
Champs-sur-Marne, , France
Research Site
Charleville-Mézières, , France
Research Site
Châlons-en-Champagne, , France
Research Site
Chelles, , France
Research Site
Cherbourg Octeville, , France
Research Site
Chevilly-Larue, , France
Research Site
Choisy-le-Roi, , France
Research site
Cholet, , France
Research Site
Colmar, , France
Research Site
Cornebarrieu, , France
Research Site
Courbevoie, , France
Research Sites
Créteil, , France
Research Site
Denain, , France
Research Site
Dieppe, , France
Research Site
Dijon, , France
Research Site
Dole, , France
Research Site
Ermont, , France
Research Site
Épernay, , France
Research Site
Épinal, , France
Research Site
Étampes, , France
Research Site
Fécamp, , France
Research Site
Forbach, , France
Research Site
Gournay-sur-Marne, , France
Research Site
Grenoble, , France
Research Site
Hagondange, , France
Research Site
Hazebrouck, , France
Research Site
Herblay-sur-Seine, , France
Research Site
Hénin-Beaumont, , France
Research Site
Hyères, , France
Research Site
Issy-les-Moulineaux, , France
Research Site
Joigny, , France
Research Site
Juan-les-Pins, , France
Research Site
La Roche-sur-Yon, , France
Research site
La Rochelle, , France
Research Site
La Teste-de-Buch, , France
Research Site
Lagardelle-sur-Lèze, , France
Research Site
Le Havre, , France
Research Site
Le Puy-en-Velay, , France
Research site
Lens, , France
Research Site
Les Mureaux, , France
Research Site
Libourne, , France
Research Site
Lille, , France
Research site
Limoges, , France
Research site
Loudéac, , France
Research site
Lunéville, , France
Research Site
Lyon, , France
Research Site
Marcq-en-Barœul, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SYMPHONIE
Identifier Type: -
Identifier Source: secondary_id
D5890L00005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.